CDKN3 and Burkitt lymphoma: For instance, miR-222-3p, which we found to be upregulated by ~7-fold in our array, has previously been shown to be downregulated in BL relative to DLBCL [33], and specifically targets the cyclin-dependent kinase inhibitor p27Kip1 [34].